Live Breaking News & Updates on Department Of Medicine Division Gastroenterology

Stay updated with breaking news from Department of medicine division gastroenterology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Study describes IgG antibodies in Crohn's disease specific for human bacterial flagellins


Study describes IgG antibodies in Crohn s disease specific for human bacterial flagellins
Last year, Charles O. Elson, M.D., demonstrated a potential preventive treatment for Crohn s disease, a form of inflammatory bowel disease. He used a mouse model that included immune-reactive T cells from patients with Crohn s disease in a flagellin peptide-specific immunotherapy.
This study provided proof-of-principle that a flagellin-directed immunotherapy might provide similar benefits in patients.
Now University of Alabama at Birmingham researchers have moved a step closer to possible clinical testing of this treatment, say Elson and co-first authors Katie Alexander, Ph.D., and Qing Zhao, M.D., Ph.D. Their study, published in the journal ....

Charleso Elson , Qing Zhao , Katie Alexander , Emily Henderson , Department Of Medicine Division Gastroenterology , University Of Alabama At Birmingham , Medicine Division , குயிங் ழோ , கேடீ அலெக்சாண்டர் , எமிலி ஹென்டர்சன் , துறை ஆஃப் மருந்து பிரிவு இரைப்பை குடல் , பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம் , மருந்து பிரிவு ,

Crohn's disease patients have specific IgG antibodies to human bacterial flagellins


 E-Mail
IMAGE: Last year, researchers used a mouse model that included immune-reactive T cells from patients with Crohn s disease in a proof-of-principle demonstration that a flagellin-directed immunotherapy might provide similar benefits in.
view more 
Credit: UAB
BIRMINGHAM, Ala. - Last year, Charles O. Elson, M.D., demonstrated a potential preventive treatment for Crohn s disease, a form of inflammatory bowel disease. He used a mouse model that included immune-reactive T cells from patients with Crohn s disease in a flagellin peptide-specific immunotherapy. This study provided proof-of-principle that a flagellin-directed immunotherapy might provide similar benefits in patients.
Now University of Alabama at Birmingham researchers have moved a step closer to possible clinical testing of this treatment, say Elson and co-first authors Katie Alexander, Ph.D., and Qing Zhao, M.D., Ph.D. Their study, published in the journal ....

United States , Peterj Mannon , Charleso Elson , Qing Zhao , Katie Alexander , Basili Hirschowitz , Alexanderf Rosenberg , Meagan Reif , National Institutes Of Health , Department Of Medicine Division Gastroenterology , University Of Alabama At Birmingham , Department Of Microbiology , Colitis Foundation Of America , Department Of Veterans Affairs , Department Of Medicine , Rainin Foundation , Medicine Division , Lennard Wayne Duck , Colitis Foundation , Veterans Affairs , National Institutes , Synergy Award , Endowed Chair , Medicine Health , Immunology Allergies Asthma , Internal Medicine ,